Cheap Stocks and Market Reforms Draw Investors to Saudi
Announced over a single week in July, a series of policy changes will allow residents of Gulf Cooperation Council countries to more freely trade Saudi stocks, give foreign firms the option of launching depositary receipts and ease rules for funds and asset managers dealing in equities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Do Hosen Group's (Catalist:5EV) Earnings Warrant Your Attention?
Explore Hosen Group's Fair Values from the Community and select yours It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Hosen Group (Catalist:5EV). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Fast Is Hosen Group Growing? If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS) outcomes. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Over the last three years, Hosen Group has grown EPS by 13% per year. That's a good rate of growth, if it can be sustained. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. Hosen Group reported flat revenue and EBIT margins over the last year. While this doesn't ring alarm bells, it may not meet the expectations of growth-minded investors. You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart. View our latest analysis for Hosen Group Hosen Group isn't a huge company, given its market capitalisation of S$15m. That makes it extra important to check on its balance sheet strength. Are Hosen Group Insiders Aligned With All Shareholders? Insider interest in a company always sparks a bit of intrigue and many investors are on the lookout for companies where insiders are putting their money where their mouth is. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, insiders are sometimes wrong, and we don't know the exact thinking behind their acquisitions. Hosen Group top brass are certainly in sync, not having sold any shares, over the last year. But more importantly, CEO & Executive Director Hock Chye Lim spent S$111k acquiring shares, doing so at an average price of S$0.041. It seems at least one insider has seen potential in the company's future - and they're willing to put money on the line. These recent buys aren't the only encouraging sign for shareholders, as a look at the shareholder registry for Hosen Group will reveal that insiders own a significant piece of the pie. In fact, they own 57% of the company, so they will share in the same delights and challenges experienced by the ordinary shareholders. This should be seen as a good thing, as it means insiders have a personal interest in delivering the best outcomes for shareholders. Of course, Hosen Group is a very small company, with a market cap of only S$15m. So this large proportion of shares owned by insiders only amounts to S$8.7m. That might not be a huge sum but it should be enough to keep insiders motivated! Does Hosen Group Deserve A Spot On Your Watchlist? One positive for Hosen Group is that it is growing EPS. That's nice to see. On top of that, we've seen insiders buying shares even though they already own plenty. That makes the company a prime candidate for your watchlist - and arguably a research priority. Still, you should learn about the 3 warning signs we've spotted with Hosen Group (including 1 which is a bit unpleasant). The good news is that Hosen Group is not the only stock with insider buying. Here's a list of small cap, undervalued companies in SG with insider buying in the last three months! Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Frontken Corporation Berhad Second Quarter 2025 Earnings: EPS: RM0.021 (vs RM0.021 in 2Q 2024)
Explore Frontken Corporation Berhad's Fair Values from the Community and select yours Frontken Corporation Berhad (KLSE:FRONTKN) Second Quarter 2025 Results Key Financial Results Revenue: RM156.4m (up 16% from 2Q 2024). Net income: RM33.5m (flat on 2Q 2024). Profit margin: 21% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: RM0.021 (in line with 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Frontken Corporation Berhad Earnings Insights Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Commercial Services industry in Asia. Performance of the market in Malaysia. The company's shares are up 6.6% from a week ago. Balance Sheet Analysis While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Frontken Corporation Berhad's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 hours ago
- Yahoo
Multi-Chem First Half 2025 Earnings: EPS: S$0.16 (vs S$0.18 in 1H 2024)
Explore Multi-Chem's Fair Values from the Community and select yours Multi-Chem (SGX:AWZ) First Half 2025 Results Key Financial Results Revenue: S$301.0m (down 12% from 1H 2024). Net income: S$14.2m (down 13% from 1H 2024). Profit margin: 4.7% (down from 4.8% in 1H 2024). The decrease in margin was driven by lower revenue. EPS: S$0.16 (down from S$0.18 in 1H 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Multi-Chem shares are up 2.2% from a week ago. Risk Analysis We should say that we've discovered 1 warning sign for Multi-Chem that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
